Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | LTB4R | Q15722 | 4/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | PAM | P19021 | 1/20 | 0.32 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6512479 | 0.99 | CES1 (0.34) | CES1LTB4RSMN1; SMN2HPGDPAM | |
| SCHEMBL6345213 | 0.85 | CES1 (0.45) | CES1LTB4RHPGDPAMMEN1 | |
| SCHEMBL6345544 | 0.83 | CES1 (0.46) | CES1LTB4RHPGDPAMMEN1 | |
| SCHEMBL7675190 | 0.74 | L3MBTL1 (0.36) | CES1LTB4RPAMALDH1A1KMT2A | |
| SCHEMBL6342780 | 0.71 | CES1 (0.41) | CES1HPGDPAMMEN1ALDH1A1 | |
| SCHEMBL3286172 | 0.70 | CES1 (0.46) | CES1LTB4RPAMKDM4EMEN1 | |
| SCHEMBL3280200 | 0.69 | CES1 (0.47) | CES1LTB4RPAMKDM4EMEN1 | |
| SCHEMBL6694767 | 0.68 | ALDH1A1 (0.33) | HPGDALDH1A1 | |
| SCHEMBL6531463 | 0.67 | CES1 (0.42) | CES1LTB4RPAMKDM4EMEN1 | |
| SCHEMBL6350509 | 0.66 | PPARA (0.41) | CES1LTB4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005068418-A1 | SULFIDE AND DISULFIDE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES | ESPERION THERAPEUTICS, INC. (US) | 2005-07-28 | — | — | WO | disclosed |
| EP-1363879-A2 | SULFIDE AND DISULFIDE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES | Esperion Therapeutics Inc. (US) | 2003-11-26 | — | — | EP | disclosed |
| WO-2002030884-A2 | SULFIDE AND DISULFIDE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES | ESPERION THERAPEUTICS, INC. (US) | 2002-04-18 | — | — | WO | disclosed |